BizWest: Opgenorth transforms canine cancer treatment
Terry Opgenorth, who holds a doctorate in physiology, built a 12-member team and went through the steps of taking an idea to market, launching the first conditionally approved drug for canine lymphoma, Tanovea-CA1.